In summary, we found that the impairment of AGO2 led to decreased miR-185-3p, which is potentially due to a loss of protection from degradation, and that miR-185-3p could regulate cell migration and invasion by directly targeting NRP1 in CRC. Here, NRP1 is linked to colorectal carcinoma.